Pfizer Pharmaceuticlas 483, Apr 2015

Pfizer Pharmaceuticlas 483, Apr 2015

Peter Baker FDA, Arsen Karapetyan FDA$119.00

FDA investigators audited the Pfizer Pharmaceuticlas facility in Dalian, China and issued inspectional observations (via FDA 483) on 17 Apr 2015.

Buy This DocumentBuy 1-Year 483 Access

Product details

  • Inspection end: 17 Apr 2015
  • Location: Dalian, China